日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Outcomes After Repeat Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy

梗阻性肥厚型心肌病患者再次行酒精间隔消融术后的结果

Hiruma, Takashi; Kitamura, Mitsunobu; Takamisawa, Itaru; Abe, Ryo; Kawai, Tosei; Funaki, Takashi; Izumi, Yuki; Higuchi, Ryosuke; Matsuda, Junya; Tokita, Yukichi; Nanasato, Mamoru; Iguchi, Nobuo; Iwakura, Tomohiro; Shimokawa, Tomoki; Takanashi, Shuichiro; Takayama, Hiroo; Shimada, Yuichi J; Takano, Hitoshi; Asai, Kuniya; Isobe, Mitsuaki; Takayama, Morimasa

A variant in HMMR/HMMR-AS1 is associated with serum alanine aminotransferase levels in the Ryukyu population

HMMR/HMMR-AS1基因的一个变异与琉球人群的血清丙氨酸氨基转移酶水平相关。

Ohyama, Noriko; Matsunami, Masatoshi; Imamura, Minako; Yoshida, Akihiro; Javed, Azeem; Liu, Xiaoxi; Kimura, Ryosuke; Matsuda, Koichi; Terao, Chikashi; Maeda, Shiro

Relationship between gastric mucosal atrophy by endoscopy and non-ampullary duodenal epithelial tumors

内镜下胃黏膜萎缩与非壶腹部十二指肠上皮肿瘤的关系

Ohno, Kazuya; Nakatani, Eiji; Kurokami, Takafumi; Kawai, Asami; Itai, Ryosuke; Matsuda, Masanori; Masui, Yuichi; Satoh, Tatsunori; Ikeda, Shinya; Hirata, Taiyo; Takeda, Shodai; Suzuki, Makoto; Haruma, Ken

Protocol digest of a randomized controlled Phase III study comparing surgery alone versus adjuvant nivolumab versus adjuvant S-1 for locally advanced oesophageal squamous cell carcinoma with no pathological complete response after neoadjuvant chemotherapy followed by curative esophagectomy: Japan Clinical Oncology Group study JCOG2206 (SUNRISE Trial)

一项随机对照 III 期研究的方案摘要,该研究比较了新辅助化疗后行根治性食管切除术但未达到病理完全缓解的局部晚期食管鳞状细胞癌患者,单独手术治疗与辅助纳武利尤单抗治疗与辅助 S-1 治疗的疗效:日本临床肿瘤协作组研究 JCOG2206(SUNRISE 试验)

Zhang, Xiaoran; Ferris, Laura; Faries, Mark B; Luke, Jason J; Kita, Ryosuke; Matsuda, Satoru; Nomura, Motoo; Machida, Ryunosuke; Sasaki, Keita; Kato, Ken; Goto, Rei; Yoshioka, Takashi; Yamamoto, Shun; Tsushima, Takahiro; Fukuda, Haruhiko; Takeuchi, Hiroya; Kitagawa, Yuko

The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients

淋巴细胞/单核细胞比值可预测伊沙妥昔单抗联合泊马度胺治疗多发性骨髓瘤患者的疗效

Shimazu, Yutaka; Kanda, Junya; Onda, Yoshiyuki; Fuchida, Shin-Ichi; Ohta, Kensuke; Shimura, Yuji; Kosugi, Satoru; Yamamura, Ryosuke; Matsuda, Mitsuhiro; Hanamoto, Hitoshi; Adachi, Yoko; Anzai, Naoyuki; Hotta, Masaaki; Fukushima, Kentaro; Yagi, Hideo; Yoshihara, Satoshi; Tanaka, Yasuhiro; Takakuwa, Teruhito; Tanaka, Hirokazu; Shibayama, Hirohiko; Uoshima, Nobuhiko; Hosen, Naoki; Ito, Tomoki; Shimazaki, Chihiro; Matsumura, Itaru; Kuroda, Junya; Takaori-Kondo, Akifumi; Hino, Masayuki

Bulk RNA sequencing reveals the comprehensive genetic characteristics of human cord blood-derived natural killer cells

批量 RNA 测序揭示人类脐带血来源的自然杀伤细胞的全面遗传特征

Takayuki Morimoto, Tsutomu Nakazawa, Ryosuke Maeoka, Ryosuke Matsuda, Mitsutoshi Nakamura, Fumihiko Nishimura, Shuichi Yamada, Ichiro Nakagawa, Young-Soo Park, Takahiro Tsujimura

Antitumor Effects of Intravenous Natural Killer Cell Infusion in an Orthotopic Glioblastoma Xenograft Murine Model and Gene Expression Profile Analysis

静脉输注自然杀伤细胞对原位胶质母细胞瘤异种移植小鼠模型的抗肿瘤作用及基因表达谱分析

Takayuki Morimoto, Tsutomu Nakazawa, Ryosuke Matsuda, Ryosuke Maeoka, Fumihiko Nishimura, Mitsutoshi Nakamura, Shuichi Yamada, Young-Soo Park, Takahiro Tsujimura, Ichiro Nakagawa

Characterization of HIF-1α Knockout Primary Human Natural Killer Cells Including Populations in Allogeneic Glioblastoma

同种异体胶质母细胞瘤中 HIF-1α 敲除原代人类自然杀伤细胞(包括细胞群)的表征

Tsutomu Nakazawa, Takayuki Morimoto, Ryosuke Maeoka, Kengo Yamada, Ryosuke Matsuda, Mitsutoshi Nakamura, Fumihiko Nishimura, Shuichi Yamada, Young-Soo Park, Takahiro Tsujimura, Ichiro Nakagawa

Transarterial embolization for anterior cranial fossa dural arteriovenous fistula based on multi-modal three-dimensional imaging

基于多模态三维成像的经动脉栓塞术治疗前颅窝硬脑膜动静脉瘘

Kotsugi, Masashi; Konishi, Kengo; Yokoyama, Shohei; Okamoto, Ai; Nakase, Kenta; Maeoka, Ryosuke; Matsuda, Ryosuke; Nakagawa, Ichiro

CIS deletion by CRISPR/Cas9 enhances human primary natural killer cell functions against allogeneic glioblastoma

CRISPR/Cas9 的 CIS 缺失增强了人类原发性自然杀伤细胞对抗同种异体胶质母细胞瘤的功能

Tsutomu Nakazawa #, Takayuki Morimoto #, Ryosuke Maeoka, Ryosuke Matsuda, Mitsutoshi Nakamura, Fumihiko Nishimura, Noriko Ouji, Shuichi Yamada, Ichiro Nakagawa, Young Soo Park, Toshihiro Ito, Hiroyuki Nakase, Takahiro Tsujimura